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Metastasis to the breast: A rare site
for secondary malignancy
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Abstract Metastases to the breast from extramammary neoplasms are rare. Few
cases of melanoma metastatic to the breast have been described in the literature.
Correct identification of metastatic breast malignancy is of great significance since
this presentation may be confused with primary benign or malignant breast disease.
ª 2005 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.Metastasis to the breast from extramammary
carcinomas is extremely rare. In 1981 Neilsen et al.
reported 15 cases and reviewed the literature
finding about 200 cases previously documented.1
In adults several tumours have been shown to me-
tastasize to the breast.
Of these the most common types are malignant
melanoma, secondary lymphomas and tumours of
neuroendocrine origin.2 Small cell carcinoma and
carcinoid tumours have been frequently reported
in adults.3e5 Other common sites include the thy-
roid, lung, stomach, cervix and uterus.6e8 In chil-
dren metastatic rhabdomyosarcoma to the breast
has been described.9
In males the prostate is the commonest site of
primary tumour metastasizing to the breast. The
lesions are typically subareolar and often occur in
males with advanced prostatic carcinoma on hor-
monal therapy.10 In female patients metastasis
may occur from a primary tumour in the contra lat-
eral breast though it may be difficult to differenti-
ate this from a second primary tumour.11
Although secondary lymphomas of the breast
are rare, they represent one of the largest group of
metastatic tumours of the breast. These patients
typically present with a painless lump in the
breast. In most series secondary lymphomas are
of the large B-cell type.12,13 The majority of1743-9191/$ - see front matter ª 2005 Surgical Associates Ltd. P
doi:10.1016/j.ijsu.2005.10.008patients who present with metastatic breast can-
cer have a known primary tumour. However,
a small subset of patients present with occult pri-
mary disease and the breast metastases are the
first manifestation of the disease.3,14
A long interval between diagnosis or the first
appearance of melanoma and breast metastases
may result in misdiagnosis of the tumour for an
infiltrating duct carcinoma.
In a review of 15 cases by Arora and Robinson
the median interval between the first diagnosis of
melanoma and breast metastases was 33 months
with one patient presenting 11 years after first
diagnosis of melanoma.15
Metastatic lesions may grow rapidly but the
majority of cases present with a firm freely mobile
lump mimicking benign disease. Rarely a large
rapidly growing lesion may be confused with in-
flammatory breast cancer.16
Mammographic examination of these lesions
usually reveals multiple lesions of similar size and
architectural density, which are frequently inter-
preted, as benign.3
Microcalcifications are usually absent.
Fine needle aspiration biopsy can be used to
distinguish metastatic deposits from primary breast
disease. Clinical correlation with previous speci-
mens, special stains and immunohistochemistry canublished by Elsevier Ltd. All rights reserved.
Editorial 205also aid in making the diagnosis. Vergier et al.
identified a number of characteristics typical of
metastases, namely atypical histologic features for
a primary breast carcinoma, a well-circumscribed
tumour with multiple satellite foci, the absence of
an intraductal component, and the presence of
many lymphatic emboli.3
Typically tumours appear discretely in the
breast displacing normal breast tissue rather than
arising form them. Dysplastic changes in the breast
such as atypical ductal hyperplasia progressing to
ductal carcinoma in situ (DCIS) are not seen.
Rarely metastatic ovarian carcinoma has been
reported to simulate DCIS.7
The treatment of secondary malignancy of
the breast should be directed at the primary
disease. Surgical therapy should be as conserva-
tive as possible and usually entails wide local
excision.
Treatment for isolated metastatic disease may
be palliated by surgical resection with long-term
survival reported occasionally.17,18 In the majority
of cases the prognosis is poor. Large bulky tumours
may be palliated by mastectomy though this pro-
cedure should be avoided where possible. The
use of chemotherapy may provide symptomatic re-
lief in some patients with prolonged survival in
specific tumours such as carcinoid, lymphomas
and choriocarcinomas that may be responsive to
chemotherapy. Survival in patients with metastatic
lymphoma is related to stage and histologic char-
acteristics. Patients with higher grade histologic
lesions or more advanced stage have a worse prog-
nosis.12 Advanced melanoma, though usually re-
fractory to systemic therapy, may occasionally
respond to treatment with biologic response modi-
fiers and cytotoxic agents. Because of the likeli-
hood of generalized metastatic disease when
non-mammary tumours spread to the breast the
average survival of patients with advanced dis-
ease, who do not respond to treatment, is usually
less than seven to nine months.
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